| 发明名称 |
IDENTIFICATION OF MHC CLASS I PHOSPHO-PEPTIDE ANTIGENS FROM BREAST CANCER UTILIZING SHLA TECHNOLOGY AND COMPLEMENTARY ENRICHMENT STRATEGIES |
| 摘要 |
The present invention describes novel tumor-specific phosphorylated peptides, nucleic acids encoding those peptides, and antibodies generated against said peptides. The genes, peptides, and antibodies described herein may be used as diagnostic indicators of the presence of breast cancer and/or used in therapeutics to treat breast cancer. |
| 申请公布号 |
US2015225456(A1) |
申请公布日期 |
2015.08.13 |
| 申请号 |
US201314403350 |
申请日期 |
2013.05.28 |
| 申请人 |
Phosimmune, INC. ;The Board of Regents of the University of Oklahoma |
发明人 |
Hunt Donald F.;Norris Andrew;English Ann Michelle;Shabanowitz Jeffrey;Hilderbrand William H.;Hawkins Oriana E. |
| 分类号 |
C07K7/08;A61K39/00;C07K16/18;C07K7/06 |
主分类号 |
C07K7/08 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An isolated phosphopeptide comprising a sequence selected from the group consisting of SEQ ID NOs: 70-171. |
| 地址 |
Charlottesville VA US |
